HBM Holdings Limited 2142.HK
2142.HK
HBM Holdings Limited 6826.HK
Shanghai Haohai Biological Technology Co., Ltd. 2171.HK
CARsgen Therapeutics Holdings Limited 2256.HK
Abbisko Cayman Limited 2616.HK
CStone Pharmaceuticals 9966.HK
Alphamab Oncology 2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 1672.HK
Ascletis Pharma Inc. 1873.HK
Viva Biotech Holdings 0775.HK
CK Life Sciences Int'l., (Holdings) Inc.
HBM Holdings Limited 6826.HK
Shanghai Haohai Biological Technology Co., Ltd. 2171.HK
CARsgen Therapeutics Holdings Limited 2256.HK
Abbisko Cayman Limited 2616.HK
CStone Pharmaceuticals 9966.HK
Alphamab Oncology 2315.HK
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. 1672.HK
Ascletis Pharma Inc. 1873.HK
Viva Biotech Holdings 0775.HK
CK Life Sciences Int'l., (Holdings) Inc.
Performance
| Periode | 2142.HK | 6826.HK | 2171.HK | 2256.HK | 2616.HK | 9966.HK | 2315.HK | 1672.HK | 1873.HK | 0775.HK |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 80.50 % | 12.45 % | 35.48 % | 128.95 % | 174.10 % | 104.68 % | 101.69 % | 90.28 % | 88.15 % | 18.42 % |
| YTD | 554.55 % | 5.86 % | 84.01 % | 255.10 % | 180.82 % | 295.63 % | 186.75 % | 190.12 % | 198.82 % | 119.51 % |
| 1Y | 920.47 % | -19.47 % | 330.42 % | 303.61 % | 282.22 % | 253.39 % | 217.76 % | 596.30 % | 176.09 % | 87.50 % |
| 3Y | 945.16 % | 64.94 % | 30.17 % | 436.30 % | 92.72 % | 129.61 % | -8.46 % | 308.70 % | 86.76 % | 45.16 % |
| 5Y | 17.60 % | -19.61 % | -42.47 % | 26.29 % | -43.61 % | -13.35 % | -8.46 % | 208.20 % | -68.76 % | 2.27 % |
| 10Y | 17.60 % | -14.94 % | -42.47 % | 26.29 % | -46.50 % | 0.52 % | -8.46 % | -32.86 % | -42.53 % | 21.62 % |
| From the beginning | 17.60 % | -35.03 % | -42.47 % | 26.29 % | -46.50 % | 0.52 % | -8.46 % | -32.86 % | -42.53 % | -69.05 % |